Port JL - Search Results

1

Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.

Altorki NK, Walsh ZH, Melms JC, Port JL, Lee BE, Nasar A, Spinelli C, Caprio L, Rogava M, Ho P, Christos PJ, Saxena A, Elemento O, Bhinder B, Ager C, Amin AD, Sanfilippo NJ, Mittal V, Borczuk AC, Formenti SC, Izar B, McGraw TE. Altorki NK, et al. Among authors: port jl. Nat Commun. 2024 Jan 3;15(1):225. doi: 10.1038/s41467-023-44575-3. Nat Commun. 2024. PMID: 38172131 Free PMC article. No abstract available.

2

Proliferative myositis: a rare pseudosarcoma of the chest wall.

Kent MS, Flieder DB, Port JL, Altorki NK. Kent MS, et al. Among authors: port jl. Ann Thorac Surg. 2002 Apr;73(4):1296-8. doi: 10.1016/s0003-4975(01)03266-0. Ann Thorac Surg. 2002. PMID: 11996276

3

Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.

Altorki N, Kent M, Ferrara C, Port J. Altorki N, et al. Ann Surg. 2002 Aug;236(2):177-83. doi: 10.1097/00000658-200208000-00005. Ann Surg. 2002. PMID: 12170022 Free PMC article.

4

Early lung cancer detection and treatment strategies.

Port JL, Kent M, Altorki NK. Port JL, et al. Surg Oncol. 2002 Dec;11(4):191-9. doi: 10.1016/s0960-7404(02)00049-x. Surg Oncol. 2002. PMID: 12450555 Review.

5

Thoracic esophageal perforations: a decade of experience.

Port JL, Kent MS, Korst RJ, Bacchetta M, Altorki NK. Port JL, et al. Ann Thorac Surg. 2003 Apr;75(4):1071-4. doi: 10.1016/s0003-4975(02)04650-7. Ann Thorac Surg. 2003. PMID: 12683539

6

Resection of a symptomatic pericardial cyst using the computer-enhanced da Vinci Surgical System.

Bacchetta MD, Korst RJ, Altorki NK, Port JL, Isom OW, Mack CA. Bacchetta MD, et al. Among authors: port jl. Ann Thorac Surg. 2003 Jun;75(6):1953-5. doi: 10.1016/s0003-4975(02)05008-7. Ann Thorac Surg. 2003. PMID: 12822644

7

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.

Altorki NK, Keresztes RS, Port JL, Libby DM, Korst RJ, Flieder DB, Ferrara CA, Yankelevitz DF, Subbaramaiah K, Pasmantier MW, Dannenberg AJ. Altorki NK, et al. Among authors: port jl. J Clin Oncol. 2003 Jul 15;21(14):2645-50. doi: 10.1200/JCO.2003.07.127. J Clin Oncol. 2003. PMID: 12860939 Clinical Trial.

8

Tumor size predicts survival within stage IA non-small cell lung cancer.

Port JL, Kent MS, Korst RJ, Libby D, Pasmantier M, Altorki NK. Port JL, et al. Chest. 2003 Nov;124(5):1828-33. doi: 10.1378/chest.124.5.1828. Chest. 2003. PMID: 14605056

9

Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: results of a phase II trial.

Keresztes RS, Port JL, Pasmantier MW, Korst RJ, Altorki NK. Keresztes RS, et al. Among authors: port jl. J Thorac Cardiovasc Surg. 2003 Nov;126(5):1603-8. doi: 10.1016/s0022-5223(03)00710-4. J Thorac Cardiovasc Surg. 2003. PMID: 14666040 Free article. Clinical Trial.

10

Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer.

Port JL, Kent MS, Korst RJ, Keresztes R, Levin MA, Altorki NK. Port JL, et al. Ann Thorac Surg. 2004 Jan;77(1):254-9; discussion 259. doi: 10.1016/s0003-4975(03)01457-7. Ann Thorac Surg. 2004. PMID: 14726072 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters